Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIA vs Nerve Block for Pain Control After Knee Replacement
NCT07744503Completed
- Sponsor
- Pangea Ventures
- Start
- Jun 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Pangea Ventures. Primary endpoint: Postoperative Pain Intensity at 48 hours. Started Jun 2025; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07744503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07744503.